Christophe Guillon

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Pathogens (Basel, Switzerland)

Biochemistry

Scientific reports

Pharmaceuticals (Basel, Switzerland)

Institut de Biologie et Chimie des Protéines

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut de Biologie et Chimie des Protéines Mar 01 2007

France

Research Scientist :: Retroviruses and Structural Biochemistry

Unité Mixte CNRS/bioMérieux Oct 01 2003 - Mar 01 2007

France

Research Scientist

Unité Mixte CNRS/bioMérieux Jun 01 2000 - Oct 01 2003

France

post-doc

Erasmus MC May 01 1996 - May 31 2000

Netherlands

post-doc :: Virology

Publications

Christophe Guillon, Xavier Robert, Patrice Gouet
"It's Only a Model": When Protein Structure Predictions Need Experimental Validation, the Case of the HTLV-1 Tax Protein. Pathogens (Basel, Switzerland) 13 (3) (2024)
Christophe Guillon, Xavier Robert, Patrice Gouet
"It's Only a Model": When Protein Structure Predictions Need Experimental Validation, the Case of the HTLV-1 Tax Protein. Pathogens (Basel, Switzerland) 13 (3) (2024)
Christophe Guillon, Xavier Robert, Patrice Gouet
"It's Only a Model": When Protein Structure Predictions Need Experimental Validation, the Case of the HTLV-1 Tax Protein. Pathogens (Basel, Switzerland) 13 (3) (2024)
Cecilia Rocchi, Camille Louvat, Adriana Erica Miele, Julien Batisse, Christophe Guillon, Lionel Ballut, Daniela Lener, Matteo Negroni, Marc Ruff, Patrice Gouet, Francesca Fiorini
The HIV-1 Integrase C-Terminal Domain Induces TAR RNA Structural Changes Promoting Tat Binding. International journal of molecular sciences 23 (22) (2022)
Mathieu Long, François-Xavier Cantrelle, Xavier Robert, Emmanuelle Boll, Natalia Sierra, Patrice Gouet, Xavier Hanoulle, Guzmán I Alvarez, Christophe Guillon
Identification of a Potential Inhibitor of the FIV p24 Capsid Protein and Characterization of Its Binding Site. Biochemistry 60 (24) (2021)
Dimitris Matiadis, Tatiana Saporiti, Elena Aguilera, Xavier Robert, Christophe Guillon, Nallely Cabrera, Ruy Pérez-Montfort, Marina Sagnou, Guzmán Alvarez
Pyrazol(in)e derivatives of curcumin analogs as a new class of anti-Trypanosoma cruzi agents. Future medicinal chemistry 13 (8) (2021)
Mathieu Long, Johan Toesca, Christophe Guillon
Review and Perspectives on the Structure-Function Relationships of the Gag Subunits of Feline Immunodeficiency Virus. Pathogens (Basel, Switzerland) 10 (11) (2021)
Florencia Ferraro, Ileana Corvo, Lucia Bergalli, Andrea Ilarraz, Mauricio Cabrera, Jorge Gil, Brian M Susuki, Conor R Caffrey, David J Timson, Xavier Robert, Christophe Guillon, Teresa Freire, Guzmán Alvarez
Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity. Scientific reports 10 (1) (2020)
Natalia Sierra, Christelle Folio, Xavier Robert, Mathieu Long, Christophe Guillon, Guzmán Alvarez
Looking for Novel Capsid Protein Multimerization Inhibitors of Feline Immunodeficiency Virus. Pharmaceuticals (Basel, Switzerland) 11 (3) (2018)

Christophe Guillon.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christophe Guillon